Supporting healthcare professionals and patients with cannabinoid-based medicines

We believe you and your patients should have the same confidence in our clinically validated cannabinoid-based medicines that you would in any other prescription pharmaceuticals. We’re passionate about contributing to world class science and conducting clinical trials to ensure we continue to deliver an evidence-based range of ethical medicines.

Zelira’s focus is on specific conditions, like chronic insomnia and autism spectrum disorder (ASD), and delivering solutions to patients who are no longer receiving a benefit from their conventional treatments.

Zelira Therapeutics has developed several pharmaceutical-grade cannabinoid-based medicines that are available in Australia and the USA.

Doctor’s Authentication

This section of the website is reserved for healthcare professionals
To access, please insert your APHRA

Start typing and press Enter to search

Shopping Cart